Biologic useInflammatory bowel diseaseIBD-MFMcorticosteroidIBDIBD-maternal
…erm birth or risk of neonatal intensive care admissions (NICU). Biologic use was not associated with adverse maternal or neonatal outcomes.C…
Entity family
Programmes, procedures, policies, and other actions being evaluated. Examples include screening, surgery, public-health programmes.
This intervention is selected. Its supporting articles are shown below.
…erm birth or risk of neonatal intensive care admissions (NICU). Biologic use was not associated with adverse maternal or neonatal outcomes.C…